2.940 20.33%

Clinical Proteomics - Journal Impact

The Journal Impact 2019-2020 of Clinical Proteomics is 2.940, which is just updated in 2020. Compared with historical Journal Impact data, the Factor 2019 of Clinical Proteomics dropped by 20.33% . The Journal Impact Quartile of Clinical Proteomics is Q2. The Journal Impact of an academic journal is a scientometric factor that reflects the yearly average number of citations that recent articles published in a given journal received. It is frequently used as a factor for the relative importance of a journal within its field; journals with higher Journal Impact are often deemed to be more important than those with lower ones. The Journal Impact measures the average number of citations received in a particular year (2019) by papers published in the journal during the two preceding years (2017-2018). Note that 2019 Journal Impact are reported in 2020; they cannot be calculated until all of the 2019 publications have been processed by the indexing agency. In addition to the 2-year Journal Impact, the 3-year Journal Impact can provide further insights and factors into the impact of Clinical Proteomics.

Clinical Proteomics Real-Time Journal Impact/Jouranl Factor Prediction & Tracking, 2020 2019 2018 2017 2016 2015 Journal Impact | Factor Trend & History - Academic Accelerator

Clinical Proteomics - Journal Impact Prediction System

Journal Impact Prediction System provides an open, transparent, and straightforward platform to help academic researchers Predict future factor and performance through the wisdom of crowds. Journal Impact Prediction System displays the exact community-driven factor without secret algorithms, hidden factors, or systematic delay.

Clinical Proteomics Journal Impact Prediction System - Factor and Trend
  • Article Volume 2017 37
  • Article Volume 2016 286
  • Article Volume 2015 278
  • ISSN
  • 15590275, 15426416
  • Open Access
  • Publisher
  • Humana Press, Inc.
  • Country/Region
  • United States
  • History
  • Categories
  • Clinical Biochemistry (Q2), Molecular Biology (Q3), Molecular Medicine (Q3)

Clinical Proteomics - ISSN

The ISSN of Clinical Proteomics is 15590275, 15426416. An ISSN is an 8-digit code used to identify newspapers, journals, magazines and periodicals of all kinds and on all media–print and electronic.

Clinical Proteomics - ISSN

Clinical Proteomics - Open Access Journal

Clinical Proteomics is an Open Access (OA) Journal. Open Access stands for unrestricted access and unrestricted reuse. With Open Access, researchers can read and build on the findings of others without restriction. Much scientific and medical research is paid for with public funds. Open Access allows taxpayers to see the results of their investment.

Clinical Proteomics - Open Access

Clinical Proteomics - Publisher

Clinical Proteomics is published by Humana Press, Inc., which is located in the United States. The Publication History of Clinical Proteomics covers 2004-ongoing.

Clinical Proteomics - Publisher

Clinical Proteomics - Categories

Clinical Proteomics is a peer-reviewed scientific journal. The scope of Clinical Proteomics covers Clinical Biochemistry (Q2), Molecular Biology (Q3), Molecular Medicine (Q3).

Clinical Proteomics - Categories

Clinical Proteomics - Journal Factors

It is impossible to get a true picture of impact using a single factor alone, so a basket of factors is needed to support informed decisions. In addition to Abbreviation, Acceptance Rate, Review Speed, Research Hotspot and Template, several advanced Journal Factors including Citescore, H-Index, Self-Citation Ratio, SJR (SCImago Journal Rank Indicator) and SNIP (Source Normalized Impact per Paper) can provide you comprehensive insights into the Clinical Proteomics.

Clinical Proteomics - Journal Metrics

Journal Ranking